Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03406351 · ClinicalTrials.gov registry record

Air Pollution, Asthma and Circadian Clocks

A clinical trial of Healthy and Asthma, sponsored by University of Pennsylvania.

Active
Registry status
20
Enrollment target
1
Study location

NCT03406351: Active study of Healthy and Asthma, sponsored by University of Pennsylvania.

NCT03406351 is a study of Healthy and Asthma that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03406351, a study of Healthy and Asthma, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

Societies become increasingly urban - more than half the world's population now lives in cities. Urbanization elevates anthropogenic (man-made) exposure to air pollutants. A clear association exists between exposure to air pollutants and exacerbations (worsening) of pre-existing asthma, incidence of nighttime asthma, difficulties with asthma control and increased disease risk. In 2012, the Public Health Management Corporation's Community Health Data Base estimated that 19.4% of adults in Philadelphia had asthma compared to a national prevalence of 7%. Asthma has a clear temporal signal. A majority of asthma patients, up to 75%, reports nighttime awakenings due to worsened cough, wheeze and dyspnea. This time-of-day-dependent exacerbation of symptoms, coined nocturnal asthma, is associated with poorer disease control, more frequent medication, and higher asthma-related morbidity and mortality. Consequently, several pathophysiological mechanisms proposed for nocturnal asthma relate to circadian clock biology. Lung function oscillates over the course of 24 hours, peaking around noon and reaching its nadir during early morning hours. Concentrations of air pollutants show oscillating patterns in urban settings. In this clinical research study, the investigators start to address how spatiotemporal fluctuations in air pollutants relate to asthma. Mechanistically, the investigators wish to address the hypothesis that microRNAs (miRs) act as interface between asthma phenotypes, circadian clocks and environmental exposure.

Primary Outcome

Relative expression normalized to housekeeping genes (GAPDH, ACTB) plotted by Expression levels of miR-142-3p will be averaged from several measurements (morning, afternoon, evening, night with target times of 08:00, 14:00, 20:00, 02:00 +/- 1 hour) scheduled over 48 hours

Conditions Studied

Interventions

  • OTHER Observational

Study Locations (1)

Pennsylvania

  • University of Pennsylvania School of Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-01-15
Est. Completion 2028-01
University of Pennsylvania

1,423 total trials

What the registry record for NCT03406351 still lists

NCT03406351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT03406351 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03406351 about?

NCT03406351 is a clinical study titled "Air Pollution, Asthma and Circadian Clocks". Societies become increasingly urban - more than half the world's population now lives in cities. Urbanization elevates anthropogenic (man-made) exposure to air pollutants. A clear association exists between exposure to air pollutants and exacerbations (worsening) of pre-existing asthma, incidence of...

What is the current status of trial NCT03406351?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2018-01-15. Estimated completion is 2028-01.

What conditions does trial NCT03406351 study?

This clinical trial studies the following conditions: Healthy, Asthma.

What interventions are being tested in trial NCT03406351?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT03406351?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03406351 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03406351's enrollment target sits among peer trials

20 861st of 1090 higher than 194 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

  • NCT01630850 · 20 participants · NA

    Islet Transplantation in Patients With "Brittle" Type I Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03406351, the US trial registry maintained by the National Library of Medicine. NCT03406351 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.